Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall - Presence of Visible Particulate Matter
Use of a non-sterile injectable product could result in fatal infections.
Italiano
Use of a non-sterile injectable product could result in fatal infections.
Failure to immediately replace the device after Message Code 102 appears may result in serious patient harm or death of the patient because the device may fail to deliver therapy when needed.
Symptoms of anaphylaxis can include wheezing or difficulty breathing; swelling of the face or throat; hives or flushing; itching; abdominal cramping, abdominal pain or vomiting; back pain or chest pain; hypotension or shock.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti informazioni sui medicinali contenenti micofenolato mofetile (MMF)/acido micofenolico (MPA) in relazione alla contraccezione.
eneral use BD syringes are cleared for immediate use in fluid aspiration and injection, but not for use as a closed container storage system for drug products.
Il Comitato di valutazione dei rischi per la farmacovigilanza (PRAC) dell’EMA ha raccomandato la sospensione delle autorizzazioni all'immissione in commercio per le soluzioni per infusione a base di amido idrossietilico (HES) in tutta l'Unione europea.
An embolism could obstruct blood flow to critical organs, leading to serious injury and/or a need to surgically extract the overflow material from the patient. Severe neurologic, cardiac, limb, renal, or gastrointestinal injury may result.
Reported pulmonary events required urgent intervention, including needle decompression or chest tube placement. Several of these events were associated with cardiopulmonary arrest and patient death.
Risks of slowed or difficult breathing, misuse, abuse, addiction, overdose, and death with these medicines outweigh their benefits in patients younger than 18.
Thu, 11 Jan 2018 00:00:00 -0500
80.211.154.110